Microscopic polyangiitis affects the smaller arteries and is the most common form of arteritis. There may be a history of hypersensitivity to drugs or foreign proteins, and the natural history is a short duration of vasculitis in the small veins, arteries and capillaries.
- microscopic polyangiitis is characterized by (1,2,3):
- renal disease
- pulmonary disease
- ANCA directed against myeloperoxidase (p-ANCA)
- characterised by (3):
- necrotising vasculitis, with few or no immune deposits, predominantly affecting small vessels (i.e. capillaries, venules or arterioles)
- necrotising arteritis involving small and medium arteries may be present
- necrotising glomerulonephritis is very common
- pulmonary capillaritis often occurs
- granulomatous inflammation is absent
This disease is uncommon with an annual incidence depending on geographic location (varying from 2.7 to 11.6 cases per million)
- most frequent in the elderly but has a wide age range with men being affected more often than women
Management
- induction treatment for most patients with ANCA associated vasculitis (AAV) should be with cyclophosphamide or rituximab and glucocorticoids
- AAV should be considered to be a chronic disease needing longterm immunosuppressive therapy
- rituximab should be considered as an alternative induction agent for those at high risk of infertility and infection
- mortality remains high, and late death is due to cardiovascular disease, infection (secondary to treatment) and malignancy
Reference:
- Davies DJ. Small vessel vasculitis. Cardiovascular Pathology 2005; 14 (6): 335-346.
- ARC Autumn 2012. Topical Reviews - ANCA-associated vasculitis; 1:1-12.
- Yates A, Watts R. ANCA-associated vasculitis. Clinical Medicine 2017 Vol 17, No 1: 60–4